RxDoctor Payments Data

Seneca Storm, MD

Pain Medicine · Reno, NVNPI 1285731588

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,332 of the $1,825 with a category attached, or 73.0%. 7 manufacturers reported payments, led by SPR Therapeutics, Inc at 59.8% of the total. 2025 is the largest year on record at $556, more than ten times the $27 reported in 2019. That places this record below the midpoint for pain medicine clinicians in NV, where the typical reported total is $2,557.

$1,825in general payments, 2019–2025

Across 20 payments — averaging $91.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • SPR Therapeutics, Inc$1K
  • Boston Scientific$461
  • Medtronic$145
  • Lilly USA, LLC$76
  • Abbott$20
  • Nevro Corp.$17
  • plus $15 from 1 others

What the payments were for

  • Travel & lodging$49327%
  • Food & beverage$1,33273%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,825 in reported general payments places this provider in the 40th percentile of 101 pain medicine providers in Nevada.

See all pain medicine providers in Nevada

Medicare billing

Part B allowed, 2024
$296,703
Medicare patients
961
Services billed
2,965

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen271$5,660
Buprenorphine21$4,112
Naloxone Hcl26$1,708
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen63$1,582
Morphine Sulfate ErMorphine Sulfate45$1,159
Buprenorphine Hcl36$1,124
Pregabalin41$927
Duloxetine Hcl56$859
Gabapentin76$847
Fentanyl13$615
Oxycodone Hcl31$516
Tizanidine Hcl25$351
Tramadol Hcl37$159
Cyclobenzaprine Hcl11$53
Meloxicam18$38

Paid to pharmacies, not to this prescriber.

Other pain medicine in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →